American Society of Nephrology Kidney Week Diabetes Management for the Nephrology Care Team 2025

The Diabetes Management for the Nephrology Care Team was a full-day Early Program held immediately prior to the main ASN Kidney Week 2025 Annual Meeting. This course was designed to address the “technological revolution” in diabetes care—specifically the rapid adoption of Continuous Glucose Monitoring (CGM) and automated insulin delivery systems—and how these tools must be adapted for patients with Chronic Kidney Disease (CKD) and kidney failure.
Held in Houston, the program emphasized a “team-based” approach, acknowledging that optimal diabetes management in nephrology requires coordination between nephrologists, pharmacists, and diabetes educators to manage complex new drug classes like GLP-1 receptor agonists and non-steroidal mineralocorticoid receptor antagonists (nsMRAs).
+ What You Will Learn
The curriculum focused on the practical implementation of new standards of care. Key learning outcomes included:

CGM Mastery: How to interpret Ambulatory Glucose Profiles (AGP) and “Time in Range” specifically for patients on dialysis, where traditional A1c metrics are often unreliable.

New Therapeutics: “How and for Whom” to prescribe new glucose-lowering therapies (SGLT2 inhibitors, GLP-1 RAs, GIP/GLP-1 co-agonists) safely in advanced CKD and transplant recipients.

Insulin Automation: Understanding the mechanics of “Closed-Loop” insulin pumps (Automated Insulin Delivery) and how to troubleshoot them in a hospital or dialysis setting.

Biomarker Nuances: Beyond A1c—using glycated albumin and fructosamine to assess glycemic control in patients with anemia or high erythrocyte turnover.

+ Event Details

Event: Diabetes Management for the Nephrology Care Team: New Technology and New Drugs

Date: November 5, 2025 (Wednesday)

Location: Room 360A, George R. Brown Convention Center, Houston, Texas, USA

Chairs: Ian de Boer, MD, MS & Joshua J. Neumiller, PharmD.

+ Who Should Attend

Nephrologists: Who are increasingly becoming the “primary” metabolic physician for their CKD patients.

Clinical Pharmacists: Managing complex medication reconciliations and dosage adjustments for renal function.

Diabetes Educators (CDCES): Working within renal clinics.

Dialysis Nurses: Who need to understand the wearable devices their patients are bringing into the dialysis unit.

+ Why Attend (or Watch)

Hands-On Experience: The live course featured a voluntary “Wear a Sensor” activity, where attendees could wear a CGM device to understand the patient experience and data flow firsthand.

“The Good, The Bad, and The Ugly”: A dedicated session on the limitations of current biomarkers in dialysis patients, helping clinicians avoid over-treating “false high” A1cs or missing “false lows.”

Transplant Focus: Specific modules on managing Post-Transplant Diabetes Mellitus (PTDM) using the newer incretin-based therapies that were previously avoided in this population.

+ Topics
The agenda included focused clinical modules:

Diagnostics & Technology:

Not Always Typical: Updates on atypical diabetes classification.

Pushing Back the Curtain: CGM use specifically in patients on hemodialysis.

Therapeutics:

Incretin Mimetics: Practical guide to using GLP-1s in the nephrology clinic.

Pumps, Pens, and New Insulins: What the nephrologist needs to know about the latest delivery devices.

Holistic Care:

Combination Therapies: Synergistic use of RAS inhibitors, SGLT2i, and nsMRAs for maximum cardio-renal protection.